MRT-5201

N/A

Report date: 2026/04/07 20:00:20

Base Information

Drug NameMRT-5201
Drug Alias NameMRT-5201
ClassificationCell and gene therapy > Gene therapy > mRNA
Mechanisms of ActionOrnithine carbamoyltransferase stimulantsRNA modulators
TargetsRibonucleic AcidOrnithine carbamoyltransferase
Therapy Area/IndicationsOrnithine Carbamoyltransferase Deficiency Disease
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusDiscontinued (Phase 2 Clinical)
Highest Status in ChinaN/A
Originator CompaniesTranslate Bio Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesTranslate Bio Inc
Active IndicationsN/A
Inactive IndicationsOrnithine Carbamoyltransferase Deficiency Disease

Other Information

ATC CodeN/A
Related LinksN/A